Diabetic Med:青年糖尿病护理研究

2018-07-04 MedSci MedSci原创

近日,国际杂志 《Diabetic Med》上在线发表一项关于2型糖尿病从小儿转移到成人护理:青年糖尿病的SEARCH研究。该研究描述了2型糖尿病患者从儿科到成人护理和血糖控制不良相关的因素,采用SEARCH在青年中开展糖尿病研究。 研究人员在<18岁的儿科医疗护理中进行了基线SEARCH访视,并且在18-25岁后进行了≥1次随访SEARCH访问。在每次就诊时,收集HbA 1c,BM

近日,国际杂志 《Diabetic Med》上在线发表一项关于2糖尿病从小儿转移到成人护理:青年糖尿病SEARCH研究。该研究描述了2糖尿病患者从儿科到成人护理和血糖控制不良相关的因素,采用SEARCH在青年中开展糖尿病研究。

研究人员在<18岁的儿科医疗护理中进行了基线SEARCH访视,并且在18-25岁后进行了≥1次随访SEARCH访问。在每次就诊时,收集HbA 1cBMI,自我报告的人口和医疗保健提供者数据。采用用多变量logistic回归分析人口因素与护理转移和血糖控制不良(HbA 1c75 mmol / mol; 9.0%)之间的关联。

研究总共对1822型糖尿病青年(男性36%,少数民族75%,肥胖者87%)进行了研究。研究发现,大多数(n = 102,56%)报告在随访中转入成人护理; 相当大比例(Ñ = 2815%)的报告没有进行护理和29%没有转入成人护理阶段。糖尿病的持续时间[比值比(OR1.4,95%置信区间(95CI1.1,1.8]诊断的年龄(OR 1.8,95CI 1.4,2.4)可以预测儿科护理。独立于性别,年龄,种族/民族或基线HbA 1c水平,转移至成人或无护理与随访时血糖控制较差的相关性较高(成人:OR 4.5,95CI 1.8,11.2;无:OR 4.6,95CI 1.4,14.6)。

研究表明,患有2型糖尿病的年轻成人在从儿科到成人护理转移过程中显示出血糖控制恶化和随访失败。本研究强调需要制定针对的临床计划和医疗保健系统政策,以保护年轻时2型糖尿病发病的青年成人。

原始出处:

S. Agarwal J. K. Raymond S. Isomet al. Transfer from paediatric to adult care for young adults with Type 2 diabetes: the SEARCH for Diabetes in Youth Study

本文系梅斯医学(MedSci)原创编译整理,转载需授权!


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2016869, encodeId=475c201686953, content=<a href='/topic/show?id=4579e6722bb' target=_blank style='color:#2F92EE;'>#糖尿病护理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76722, encryptionId=4579e6722bb, topicName=糖尿病护理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5d7367, createdName=zhwj, createdTime=Thu Sep 27 17:30:00 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1760735, encodeId=d5a91e60735ba, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Thu Dec 13 01:30:00 CST 2018, time=2018-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1638674, encodeId=bf3416386e4fd, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sat Feb 02 22:30:00 CST 2019, time=2019-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1970595, encodeId=944d19e05954e, content=<a href='/topic/show?id=fa5d5919df' target=_blank style='color:#2F92EE;'>#Diabetic#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5919, encryptionId=fa5d5919df, topicName=Diabetic)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8949377, createdName=chenzhuanggui, createdTime=Mon May 27 21:30:00 CST 2019, time=2019-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608929, encodeId=3b2816089290b, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Jul 06 04:30:00 CST 2018, time=2018-07-06, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2016869, encodeId=475c201686953, content=<a href='/topic/show?id=4579e6722bb' target=_blank style='color:#2F92EE;'>#糖尿病护理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76722, encryptionId=4579e6722bb, topicName=糖尿病护理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5d7367, createdName=zhwj, createdTime=Thu Sep 27 17:30:00 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1760735, encodeId=d5a91e60735ba, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Thu Dec 13 01:30:00 CST 2018, time=2018-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1638674, encodeId=bf3416386e4fd, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sat Feb 02 22:30:00 CST 2019, time=2019-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1970595, encodeId=944d19e05954e, content=<a href='/topic/show?id=fa5d5919df' target=_blank style='color:#2F92EE;'>#Diabetic#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5919, encryptionId=fa5d5919df, topicName=Diabetic)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8949377, createdName=chenzhuanggui, createdTime=Mon May 27 21:30:00 CST 2019, time=2019-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608929, encodeId=3b2816089290b, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Jul 06 04:30:00 CST 2018, time=2018-07-06, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2016869, encodeId=475c201686953, content=<a href='/topic/show?id=4579e6722bb' target=_blank style='color:#2F92EE;'>#糖尿病护理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76722, encryptionId=4579e6722bb, topicName=糖尿病护理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5d7367, createdName=zhwj, createdTime=Thu Sep 27 17:30:00 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1760735, encodeId=d5a91e60735ba, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Thu Dec 13 01:30:00 CST 2018, time=2018-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1638674, encodeId=bf3416386e4fd, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sat Feb 02 22:30:00 CST 2019, time=2019-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1970595, encodeId=944d19e05954e, content=<a href='/topic/show?id=fa5d5919df' target=_blank style='color:#2F92EE;'>#Diabetic#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5919, encryptionId=fa5d5919df, topicName=Diabetic)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8949377, createdName=chenzhuanggui, createdTime=Mon May 27 21:30:00 CST 2019, time=2019-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608929, encodeId=3b2816089290b, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Jul 06 04:30:00 CST 2018, time=2018-07-06, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2016869, encodeId=475c201686953, content=<a href='/topic/show?id=4579e6722bb' target=_blank style='color:#2F92EE;'>#糖尿病护理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76722, encryptionId=4579e6722bb, topicName=糖尿病护理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5d7367, createdName=zhwj, createdTime=Thu Sep 27 17:30:00 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1760735, encodeId=d5a91e60735ba, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Thu Dec 13 01:30:00 CST 2018, time=2018-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1638674, encodeId=bf3416386e4fd, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sat Feb 02 22:30:00 CST 2019, time=2019-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1970595, encodeId=944d19e05954e, content=<a href='/topic/show?id=fa5d5919df' target=_blank style='color:#2F92EE;'>#Diabetic#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5919, encryptionId=fa5d5919df, topicName=Diabetic)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8949377, createdName=chenzhuanggui, createdTime=Mon May 27 21:30:00 CST 2019, time=2019-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608929, encodeId=3b2816089290b, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Jul 06 04:30:00 CST 2018, time=2018-07-06, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2016869, encodeId=475c201686953, content=<a href='/topic/show?id=4579e6722bb' target=_blank style='color:#2F92EE;'>#糖尿病护理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76722, encryptionId=4579e6722bb, topicName=糖尿病护理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5d7367, createdName=zhwj, createdTime=Thu Sep 27 17:30:00 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1760735, encodeId=d5a91e60735ba, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Thu Dec 13 01:30:00 CST 2018, time=2018-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1638674, encodeId=bf3416386e4fd, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sat Feb 02 22:30:00 CST 2019, time=2019-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1970595, encodeId=944d19e05954e, content=<a href='/topic/show?id=fa5d5919df' target=_blank style='color:#2F92EE;'>#Diabetic#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5919, encryptionId=fa5d5919df, topicName=Diabetic)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8949377, createdName=chenzhuanggui, createdTime=Mon May 27 21:30:00 CST 2019, time=2019-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608929, encodeId=3b2816089290b, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Jul 06 04:30:00 CST 2018, time=2018-07-06, status=1, ipAttribution=)]

相关资讯

PNAS:香港中文大学深圳研究所黄聿研究组揭示了血清外泌体糖尿病方面的重要作用

2018年7月2日,香港中文大学深圳研究所黄聿研究组等人在PNSA上在线发表了题为“Serum exosomes mediate delivery of arginase 1 as a novel mechanism for endothelial dysfunction in diabetes”的文章,该文章表明SExos将精氨酸酶1蛋白质递送至内皮细胞,替代了糖尿病内皮功能障碍发展过程中的细胞

Cancer Causes Control:进行局部前列腺癌雄激素阻断治疗糖尿病患者的糖尿病并发症风险研究

雄激素阻断治疗(ADT)在局部前列腺癌治疗中使用逐渐增加,且与随后的长期副作用结果相关,包括糖尿病。虽然之前的研究表明了ADT能够在糖尿病患者中对血糖控制起不良作用,但它与糖尿病并发症之间的相关性还没有调查过。最近,有研究人员调查了ADT治疗与前列腺癌患者糖尿病并发症之间的相关性。研究是一个回顾性的群体研究,并且在新诊断为局部前列腺癌患者中进行,时间为1995年到2008年之间。研究群体为经历根治

JAMA:真实世界研究证实中性鱼精蛋白胰岛素与长效胰岛素类似物对预防低血糖和控制血糖方面的差异不显著

真实世界研究发现,中性鱼精蛋白胰岛素与长效胰岛素类似物对预防低血糖和控制血糖方面的差异不显著

Nat Med:”神药“二甲双胍竟能逆转肺纤维化?

提到二甲双胍(metformin),人们最先想到的是它是治疗2型糖尿病的药物。确实,二甲双胍是治疗2型糖尿病的一线药物,通常2型糖尿病患者最先服用的药物就是它。但今日在《Nature Medicine》上发表的一项科学研究表明它还有让人意想不到的功用,美国阿拉巴马大学伯明翰分校(University of Alabama at Birmingham, UAB)的研究人员发现它可以逆转已经产生的肺纤

Diabetologia:糖尿病和怀孕事件15年的发展趋势

近日,国际杂志 《Diabetologia》上在线发表一项关于糖尿病和怀孕15年间的全国趋势的研究。研究人员目的是检查先前存在的1型或2型糖尿病妊娠结局的时间趋势。 研究人员使用苏格兰发病率记录(SMR02)分析了1998年4月1日至2013年3月31日期间(n = 813,921)所有产科住院分娩事件(活体或死产)的发作级别数据。 从全国糖尿病数据库(苏格兰医疗保健信息-糖尿病)中鉴定出患

当糖尿病与甲亢“难舍难分”,你需要避开这些坑!

患者刘女士今年40出头,在一家公司任人事。两年前因口渴、乏力、明显消瘦,经医院检查确诊为2型糖尿病。此后,刘女士一直坚持正规治疗,血糖控制良好,“三多一少”症状(吃得多、饮得多、尿得多,人消瘦)完全消失。